Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
You can purchase shares of Sage Therapeutics (NASDAQ:SAGE) through any online brokerage.
Other companies in Sage Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR) and Inozyme Pharma (NASDAQ:INZY).
Sage Therapeutics has a consensus price target of $15.05.
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $6.08 last updated October 31, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Sage Therapeutics.
Sage Therapeutics’s Q3 earnings are confirmed for Tuesday, October 29, 2024.
There is no upcoming split for Sage Therapeutics.
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.